Advancing ME/CFS Research: Identifying Targets for Intervention and Learning from Long COVID [ME/CFS Research Conference]

Event Information

The NIH sponsored conference entitled “Advancing ME/CFS Research: Identifying Targets for Intervention and Learning from Long COVID” will take place in Masur Auditorium, Clinical Center on the NIH Campus on December 12-13, 2023. The goal of the conference is to present the state of the science of ME/CFS research and identify targets for potential interventions that have arisen from the literature and clinical evidence from ME/CFS and Long COVID observations. The audience is expected to be scientists, clinicians, individuals with lived experience and other ME/CFS stakeholders. The Conference will be hybrid and will be webcast and publicly available.

Conference Organizing Committee

Co-Chairs of the Conference are Andrew Grimson, PhD from Cornell University and Nancy Klimas, MD from Nova Southeastern University. Additional Committee members: Oved Amitay, Solve MECFS Initiative; Megan Carnes, PhD, RTI; Cort Johnson, Health Rising; Laurie Jones, #MEAction; Avindra Nath, MD, NIH/NINDS; Linda Tannenbaum, Open Medicine Foundation; Jarred Younger, PhD, University of Alabama, Birmingham; Joseph Breen, PhD, NIH/NIAID; Vicky Whittemore, PhD, NIH/NINDS

Registration

Registration is now open for the upcoming research conference, “Advancing ME/CFS Research: Identifying Targets for Intervention and Learning from Long COVID,” which will take place on December 12-13, 2023 at NIH Campus in Bethesda, MD. This will be a hybrid meeting where you may attend in-person, or virtually via your browser by joining the NIH Videocast, a live-streaming video platform. For more information about the conference, click here.

Draft Agenda

Advancing ME/CFS Research: Identifying Targets for Intervention and Learning from Long COVID

DAY 1 – December 12, 2023

Welcome – Joe Breen (NIAID) and Vicky Whittemore (NINDS)

Walter Koroshetz, MD; Director, NINDS

Session One (Immunology)

Individual with Lived Experience – TBN

Mark Davis, PhD – Stanford University

Derya Unutmaz, PhD – Jackson Laboratories

Additional Speakers – TBN

Late-breaking presentation(s) from Young Investigator Workshop

Session Two (Virology)

Individual with Lived Experience – TBN

W. Ian Lipkin, MD – Columbia University

Avindra Nath, MD – NIH/NINDS

Additional Speakers – TBN

Late-breaking presentation(s) from Young Investigator Workshop

Session Three (Metabolism)

Individual with Lived Experience – TBN

Maureen Hanson, PhD – Cornell University

Karl Johan Tronstad, PhD – University of Bergen

David Systrom, Jr., MD – Brigham and Women’s Hospital

Additional Speakers – TBN

Late-breaking presentation(s) from Young Investigator Workshop

Session Four (Reports)

ME/CFS Research Roadmap Report

Lucinda Bateman, MD – Bateman Horne Center

Maureen Hanson, PhD – Cornell University

Additional reports – TBD

END of DAY 1


DAY 2 – December 13, 2023

Session Five (Long COVID and ME/CFS)

Individual with Lived Experience – TBN

Lucinda Bateman, MD – Bateman Horne Center

Additional Speakers – TBN

Late-breaking presentation(s) from Young Investigator Workshop

Session Six (Gene Regulation)

Andrew Grimson, PhD – Cornell University

Alain Moreau, PhD – University of Montreal

Additional Speakers – TBN

Late-breaking presentation(s) from Young Investigator Workshop

Session Seven (Neurology)

Individual with Lived Experience – TBN

Jarred Younger, PhD – University of Alabama, Birmingham

Additional Speakers – TBN

Late-breaking presentation(s) from Young Investigator Workshop

Session Eight (Microbiome)

Individual with Lived Experience – TBN

Speakers – TBN

Late-breaking presentation(s) from Young Investigator Workshop

Session Nine (Synthesis and Integration – panel discussion)

Panelists – TBN

Summary and Closing Thoughts